Vanda Pharmaceuticals (VNDA) Capital Expenditures Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 227.76% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.57% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 143.40% |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | -49.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.31% |
| Dec 31, 2025 | -52.34% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 176.85% |
| Mar 31, 2025 | 6,128.57% |
| Dec 31, 2024 | -15.42% |
| Sep 30, 2024 | 570.83% |
| Jun 30, 2024 | 96.36% |
| Mar 31, 2024 | -86.27% |
| Dec 31, 2023 | -3.80% |
| Sep 30, 2023 | -83.78% |
| Jun 30, 2023 | -71.50% |
| Mar 31, 2023 | -32.00% |
| Dec 31, 2022 | 96.27% |
| Sep 30, 2022 | 1,580.00% |
| Jun 30, 2022 | -35.23% |
| Mar 31, 2022 | -42.31% |
| Dec 31, 2021 | -86.13% |
| Sep 30, 2021 | -104.07% |
| Jun 30, 2021 | 41.90% |
| Mar 31, 2021 | -65.15% |
| Dec 31, 2020 | 1,320.59% |
| Sep 30, 2020 | -16.33% |
| Jun 30, 2020 | -20.45% |
| Mar 31, 2020 | -5.09% |
| Dec 31, 2019 | 209.09% |
| Sep 30, 2019 | 116.18% |
| Jun 30, 2019 | 252.00% |
| Mar 31, 2019 | 191.11% |
| Dec 31, 2018 | -88.48% |
| Sep 30, 2018 | -63.34% |
| Jun 30, 2018 | -87.98% |
| Mar 31, 2018 | -71.76% |
| Dec 31, 2017 | -72.60% |
| Sep 30, 2017 | -38.06% |
| Dec 31, 2016 | -2.38% |
| Sep 30, 2016 | -31.46% |
| Dec 31, 2015 | 111.24% |
| Sep 30, 2015 | 1,549.06% |
| Jun 30, 2015 | -35.80% |
| Mar 31, 2015 | 480.00% |
| Dec 31, 2014 | 248.45% |
| Sep 30, 2014 | 657.14% |
| Jun 30, 2014 | 395.92% |
| Mar 31, 2014 | 486.96% |
| Dec 31, 2013 | 1,285.71% |
| Sep 30, 2013 | -58.82% |
| Jun 30, 2013 | -66.89% |
| Mar 31, 2013 | -98.75% |
| Dec 31, 2012 | -90.91% |
| Sep 30, 2012 | -50.00% |